• Michael Meyers, M.P.H.

    Managing Director, Head of Investment Banking

  • 2049 Century Park East, Suite 320
    Los Angeles, CA 90067

Mr. Meyers is Managing Director and Head of Investment Banking at T.R. Winston & Company, with over 23 years of experience in investment banking, venture capital and asset management. Prior to joining T.R. Winston, Mr. Meyers was the CEO and Chief Investment Officer of Arcoda Capital Management LP, a healthcare focused fund. Prior to founding Arcoda in 2007, Mr. Meyers was a Partner and Portfolio Manager with GoldenTree Asset Management LP, a $17 billion multi-strategy asset management firm. Between 2002 and 2006, Mr. Meyers was a founding Managing Partner, Portfolio Manager and Sector Head of Healthcare of Trivium Capital Management LLC. Between 2000 and 2003, Mr. Meyers was a Managing Director, Partner and member of the Board of Directors of Global Biomedical Partners AG, a life sciences venture capital and private equity firm located in New York and Zurich, Switzerland that was acquired by HBM Bioventures in 2003.

Prior, Mr. Meyers was Director and Relationship Manager, Biotechnology and Pharmaceutical Investment Banking with Merrill Lynch & Co. Mr. Meyers was also a Vice President of Health Care Investment Banking with Cowen & Company.  Mr. Meyers began his career as a Biotechnology and Medical Device Research Associate at Hambrecht & Quist in New York. Mr. Meyers serves on the Board of Trustees of the Ronald Reagan UCLA Medical Center, the Board of Councilors of the University of Southern California’s School of Dramatic Arts and the Board of Directors of The JED Foundation.  He holds an M.P.H. in Health Policy and Management from Columbia University, and an A.B. in Biology from Brandeis University.  Mr. Meyers holds FINRA Series 7, 63 and 79 licenses.